/CHEOF

CHEOF Stock - Cochlear Limited

Q: What is the analyst price target for CHEOF?

Analyst price target information is not currently available for CHEOF.

Q: What is CHEOF's market cap?

Market capitalization information is not currently available for CHEOF.

Healthcare|Medical - Devices|OTC

$172.58+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $189.84

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CHEOF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.46

52W High$207.85

52W Low$148.62

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$2.34B	$2.24B	$1.94B	$1.65B	$1.50B
Gross Profit	$1.73B	$1.67B	$1.45B	$1.24B	$1.09B
Gross Margin	73.7%	74.9%	74.8%	75.1%	72.6%
Operating Income	$406.10M	$475.00M	$389.50M	$402.40M	$370.20M
Net Income	$388.90M	$356.80M	$300.60M	$289.10M	$326.50M
Net Margin	16.6%	16.0%	15.5%	17.5%	21.8%
EPS	$5.93	$5.43	$4.57	$4.40	$4.93

Company Overview

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Visit Website

Earnings History & Surprises

CHEOF

Beat Rate

50%

Last 12 quarters

Avg Surprise

-279.4%

EPS vs Estimate

Beats / Misses

6/6

Last 12 quarters

Latest EPS

$1.87

Q3 2025

EPS Surprise History

Q4 21

+28.1%

$1.87vs$1.46

Q2 22

-0.8%

$1.25vs$1.26

Q4 22

+2.1%

$1.47vs$1.44

Q2 23

-1.8%

$1.60vs$1.63

Q1 24

+1.5%

$1.98vs$1.95

Q3 24

-18.8%

$1.68vs$2.07

Q1 25

+0.5%

$1.93vs$1.92

Q3 25

-3.6%

$1.87vs$1.94

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Feb 11, 2026	—	—	—	—
Q3 2025	Aug 14, 2025	$1.94	$1.87	-3.6%	✗ MISS
Q1 2025	Feb 13, 2025	$1.92	$1.93	+0.5%	✓ BEAT
Q3 2024	Aug 15, 2024	$2.07	$1.68	-18.8%	✗ MISS
Q1 2024	Feb 18, 2024	$1.95	$1.98	+1.5%	✓ BEAT
Q2 2023	Jun 30, 2023	$1.63	$1.60	-1.8%	✗ MISS
Q4 2022	Dec 31, 2022	$1.44	$1.47	+2.1%	✓ BEAT
Q2 2022	Jun 30, 2022	$1.26	$1.25	-0.8%	✗ MISS
Q4 2021	Dec 31, 2021	$1.46	$1.87	+28.1%	✓ BEAT
Q2 2021	Jun 30, 2021	$1.34	$1.03	-23.1%	✗ MISS
Q4 2020	Dec 31, 2020	$0.76	$2.76	+264.6%	✓ BEAT
Q2 2020	Jun 30, 2020	$0.13	$-4.66	-3611.4%	✗ MISS
Q4 2019	Dec 31, 2019	$1.75	$1.92	+9.7%	✓ BEAT
Q2 2019	Jun 30, 2019	—	$1.79	—	—
Q4 2018	Dec 31, 2018	—	$1.72	—	—
Q2 2018	Jun 30, 2018	—	$1.72	—	—
Q4 2017	Dec 31, 2017	—	$1.48	—	—
Q2 2017	Jun 30, 2017	—	$1.49	—	—
Q4 2016	Dec 31, 2016	—	$1.40	—	—
Q2 2016	Jun 30, 2016	—	$1.24	—	—